Clinical features of myasthenia gravis patients with autoimmune thyroid disease in Taiwan

Acta Neurologica Scandinavica

Volumn 127, Issue 3, 2013, Pages 170-174

  Chen, Y L ^a   Yeh, J H ^a,b   Chiu, H C ^a,b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Autoimmune thyroid disease; Clinical features; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; ONSET AGE; PRESCHOOL CHILD; PREVALENCE; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE; TAIWAN; THYMOMA; THYMUS HYPERPLASIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREVALENCE; TAIWAN; THYROIDITIS, AUTOIMMUNE; YOUNG ADULT;

EID: 84873993220     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2012.01693.x     Document Type: Article

References (27)

1. Kiessling WR, Pflughaupt KW, Ricker K, Haubitz I, Mertens HG. Thyroid function and circulating antibodies in myasthenia gravis. Neurology 1981;31:771-4.
2. Niraj M, John W, Martin RT. When to consider thyroid dysfunction in the neurology clinic. Pract Neurol 2009;9:145-56.
3. Lai CH, Tseng HF. Nationwide population-based epidemiological study of myasthenia gravis in Taiwan. Neuroepidemiology 2010;35:66-71.
4. Kiessling WR, Finke R, Kotulla P, Schleusener H. Circulating TSH-binding inhibiting immunoglobulins in myasthenia gravis. Acta Endocrinol (Copenh) 1982;101:41-6.
5. Peacey SR, Belchetz PE. Graves' disease associated with ocular myasthenia gravis and thymic cyst. J R Soc Med 1993;86:297-8.
6. Kanazawa M, Shimohana T, Tanaka K, Nishizawa M. Clinical features of patients with myasthenia gravis associated with autoimmune diseases. Eur J Neurol 2007;14:1403-4.
7. Osserman KE, Genkins G. Studies in myasthenia gravis. Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
8. Sahey BM, Blendis LM, Greene R. Relation between myasthenia gravis and thyroid disease. Br Med J 1965;1:762-5.
9. Simpson JF, Westerbero MR, Magee KR. Myasthenia gravis. An analysis of 295 cases. Acta Neurol Scand 1966;42(Suppl. 23):1-27.
10. Mao ZF, Yang LX, Mo XA et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Intern J Neurosci 2011;121:121-9.
11. Swain M, Swain T, Mohanty BK. Autoimmune thyroid disorders-an update. Indian J Clin Biochem 2005;20:9-17.
12. Chen YP, Wei DN, Chen B. The clinical features of myasthenia gravis associated with thyroid abnormalities. Chin J Intern Med 2010;49:602-5.
13. Mantegazza R, Baggi F, Antozzi C et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 2003;998:413-23.
14. Ohno M, Hamada N, Yamakawa J, Noh J, Morii H, Ito K. Myasthenia gravis associated with Graves' disease in Japan. Jpn J Med 1987;26:2-6.
15. Ratanakorn D, Vejjajiva A. Long-term follow-up of myasthenia gravis patients with hyperthyroidism. Acta Neurol Scand 2002;106:93-8.
16. Osserman KE. Myasthenia gravis. New York: Grune and Stratton, 1953;80
17. Seybold MB. Myasthenia gravis: a clinical and basic science review. JAMA 1983;205:2516-21.
18. Garlepp MJ, Dawkins RI, Christiansen FT. Autoimmunity in ocular and generalized myasthenia gravis. J Neuroimmunol 1981;1:325-32.
19. Marino M, Ricciardi R, Pinchera A et al. Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab 1997;82:438-43.
20. Zimmermann CW, Eblen F. Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ. Clin Invest 1993;71:445-51.
21. Ludgate M, Swillens S, Mercken L, Vassart G. Homology between thyroglobulin and acetylcholinesterase: an explanation for pathogenesis of Graves' ophthalmopathy? Lancet 1986;2:219-20.
22. Ludgate M, Dong Q, Soreq H, Mariotti S, Vassart G. The pathophysiological significance of a thyroglobulin-acetylcholinesterase shared epitope in patients with Graves' ophthalmopathy. Acta Endocrinol (Copenh) 1989;121:38-45.
23. Pirskanen R, Tilikainen A, Hokkanen E. Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report. Ann Clin Res 1972;4:304-6.
24. Feltkamp TEW, Van Der Berg-Loonen PM. Myasthenia gravis, autoantibodies and HLA antigens. Br Med J 1974;1:131-3.
25. Vincent A, Bowen J, Newsom-Davis J, Mcconville J. Seronegative generalized myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2003;2:99-106.
26. Kaminski HJ, Li Z, Richmonds C, Ruff RL, Kusner L. Susceptibility of ocular tissues to autoimmune diseases. Ann N Y Acad Sci 2003;998:362-74.
27. Maruyama E, Minami N, Niino M et al. Impact of screening with thyroid ultrasonography in myasthenia gravis patients. Acta Neurol Scand 2012;125:398-402.